About this Journal Submit a Manuscript Table of Contents
Scientifica
Volume 2014 (2014), Article ID 757549, 13 pages
http://dx.doi.org/10.1155/2014/757549
Review Article

Targeting mRNA for Alzheimer’s and Related Dementias

Brigham and Women’s Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, H.I.M. 754, Boston, MA 02115, USA

Received 21 January 2014; Accepted 20 March 2014; Published 27 April 2014

Academic Editor: Monica Garcia-Alloza

Copyright © 2014 Michael S. Wolfe. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. A. Ross and M. A. Poirier, “Protein aggregation and neurodegenerative disease,” Nature Medicine, vol. 10, supplement, pp. S10–S17, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Goedert and M. G. Spillantini, “A century of Alzheimer's disease,” Science, vol. 314, no. 5800, pp. 777–781, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. R. E. Tanzi and L. Bertram, “Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective,” Cell, vol. 120, no. 4, pp. 545–555, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Benilova, E. Karran, and B. de Strooper, “The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes,” Nature Neuroscience, vol. 15, no. 3, pp. 349–357, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. R. M. Koffie, M. Meyer-Luehmann, T. Hashimoto et al., “Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 10, pp. 4012–4017, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. M. D. Weingarten, A. H. Lockwood, S. Y. Hwo, and M. W. Kirschner, “A protein factor essential for microtubule assembly,” Proceedings of the National Academy of Sciences of the United States of America, vol. 72, no. 5, pp. 1858–1862, 1975. View at Scopus
  7. D. W. Cleveland, S. Y. Hwo, and M. W. Kirschner, “Purification of tau, a microtubule associated protein that induces assembly of microtubules from purified tubulin,” Journal of Molecular Biology, vol. 116, no. 2, pp. 207–225, 1977. View at Scopus
  8. A. Himmler, D. Drechsel, M. W. Kirschner, and D. W. Martin Jr., “Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains,” Molecular and Cellular Biology, vol. 9, no. 4, pp. 1381–1388, 1989. View at Scopus
  9. K. A. Butner and M. W. Kirschner, “Tau protein binds to microtubules through a flexible array of distributed weak sites,” The Journal of Cell Biology, vol. 115, no. 3, pp. 717–730, 1991. View at Publisher · View at Google Scholar · View at Scopus
  10. B. L. Goode and S. C. Feinstein, “Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau,” The Journal of Cell Biology, vol. 124, no. 5, pp. 769–781, 1994. View at Scopus
  11. C. Ballatore, V. M.-Y. Lee, and J. Q. Trojanowski, “Tau-mediated neurodegeneration in Alzheimer's disease and related disorders,” Nature Reviews Neuroscience, vol. 8, no. 9, pp. 663–672, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. E. D. Roberson, K. Scearce-Levie, J. J. Palop et al., “Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model,” Science, vol. 316, no. 5825, pp. 750–754, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Clavaguera, T. Bolmont, R. A. Crowther et al., “Transmission and spreading of tauopathy in transgenic mouse brain,” Nature Cell Biology, vol. 11, no. 7, pp. 909–913, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. A. de Calignon, M. Polydoro, M. Suárez-Calvet et al., “Propagation of tau pathology in a model of early Alzheimer's disease,” Neuron, vol. 73, no. 4, pp. 685–697, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Liu, V. Drouet, J. W. Wu et al., “Trans-synaptic spread of tau pathology in vivo,” PLoS ONE, vol. 7, no. 2, Article ID e31302, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. V. M.-Y. Lee, M. Goedert, and J. Q. Trojanowski, “Neurodegenerative tauopathies,” Annual Review of Neuroscience, vol. 24, pp. 1121–1159, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Rademakers, M. Neumann, and I. R. Mackenzie, “Advances in understanding the molecular basis of frontotemporal dementia,” Nature Reviews Neurology, vol. 8, no. 8, pp. 423–434, 2012.
  18. M. Hutton, C. L. Lendon, P. Rizzu et al., “Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17,” Nature, vol. 393, no. 6686, pp. 702–705, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. M. G. Spillantini, J. R. Murrell, M. Goedert, M. R. Farlow, A. Klug, and B. Ghetti, “Mutation in the tau gene in familial multiple system tauopathy with presenile dementia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 13, pp. 7737–7741, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. M. S. Wolfe, “Tau mutations in neurodegenerative diseases,” The Journal of Biological Chemistry, vol. 284, no. 10, pp. 6021–6025, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. S. L. Cole and R. Vassar, “The role of amyloid precursor protein processing by BACE1, the β-secretase, in Alzheimer disease pathophysiology,” The Journal of Biological Chemistry, vol. 283, no. 44, pp. 29621–29625, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. B. de Strooper, T. Iwatsubo, and M. S. Wolfe, “Presenilins and gamma-secretase: structure, function, and role in Alzheimer disease,” Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 1, Article ID a006304, 2012.
  23. A. K. Ghosh, S. Gemma, and J. Tang, “β-secretase as a therapeutic target for Alzheimer's disease,” Neurotherapeutics, vol. 5, no. 3, pp. 399–408, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. D. J. Selkoe and M. S. Wolfe, “Presenilin: running with scissors in the membrane,” Cell, vol. 131, no. 2, pp. 215–221, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Kopan and M. X. G. Ilagan, “γ-secretase: proteasome of the membrane?” Nature Reviews Molecular Cell Biology, vol. 5, no. 6, pp. 499–504, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. T. E. Golde, E. H. Koo, K. M. Felsenstein, B. A. Osborne, and L. Miele, “gamma-secretase inhibitors and modulators,” Biochimica et Biophysica Acta, vol. 1828, no. 12, pp. 2898–2907, 2013.
  27. D. Schenk, G. S. Basi, and M. N. Pangalos, “Treatment strategies targeting amyloid beta-protein,” Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 9, Article ID a006387, 2012.
  28. S. Salloway, R. Sperling, N. C. Fox et al., “Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease,” The New England Journal of Medicine, vol. 370, pp. 322–333, 2014.
  29. R. S. Doody, R. G. Thomas, M. Farlow et al., “Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease,” The New England Journal of Medicine, vol. 370, pp. 311–321, 2014. View at Publisher · View at Google Scholar
  30. V. Tell and A. Hilgeroth, “Recent developments of protein kinase inhibitors as potential AD therapeutics,” Frontiers in Cellular Neuroscience, vol. 7, article 189, 2013.
  31. G. V. W. Johnson and W. H. Stoothoff, “Tau phosphorylation in neuronal cell function and dysfunction,” Journal of Cell Science, vol. 117, no. 24, pp. 5721–5729, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Goedert and R. Jakes, “Mutations causing neurodegenerative tauopathies,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1739, no. 2, pp. 240–250, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. D. J. Nicholl, M. A. Greenstone, C. E. Clarke et al., “An english kindred with a novel recessive tauopathy and respiratory failure,” Annals of Neurology, vol. 54, no. 5, pp. 682–686, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Grover, H. Houlden, M. Baker et al., “5′ splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10,” The Journal of Biological Chemistry, vol. 274, no. 21, pp. 15134–15143, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Varani, M. Hasegawa, M. G. Spillantini et al., “Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 14, pp. 8229–8234, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. C. P. Donahue, C. Muratore, J. Y. Wu, K. S. Kosik, and M. S. Wolfe, “Stabilization of the tau exon 10 stem loop alters pre-mRNA splicing,” The Journal of Biological Chemistry, vol. 281, no. 33, pp. 23302–23306, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. Z. Jiang, J. Cote, J. M. Kwon, A. M. Goate, and J. Y. Wu, “Aberrant splicing of tau pre-mRNA caused by intronic mutations associated with the inherited dementia frontotemporal dementia with parkinsonism linked to chromosome 17,” Molecular and Cellular Biology, vol. 20, no. 11, pp. 4036–4048, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. C. P. Donahue, J. Ni, E. Rozners, M. A. Glicksman, and M. S. Wolfe, “Identification of tau stem loop RNA stabilizers,” Journal of Biomolecular Screening, vol. 12, no. 6, pp. 789–799, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Zheng, Y. Chen, C. P. Donahue, M. S. Wolfe, and G. Varani, “Structural basis for stabilization of the tau pre-mRNA splicing regulatory element by novantrone (mitoxantrone),” Chemistry and Biology, vol. 16, no. 5, pp. 557–566, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. L. Yang, E. Peacey, J. Dickson et al., “Mitoxantrone analogues as ligands for a stem-loop structure of tau pre-mRNA,” Journal of Medicinal Chemistry, vol. 52, no. 21, pp. 6523–6526, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. N. Sergeant, A. Wattez, and A. Delacourte, “Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively “exon 10” isoforms,” Journal of Neurochemistry, vol. 72, no. 3, pp. 1243–1249, 1999. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Ingelsson, K. Ramasamy, I. Cantuti-Castelvetri et al., “No alteration in tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer's disease brain,” Acta Neuropathologica, vol. 112, no. 4, pp. 439–449, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Conrad, J. Zhu, C. Conrad et al., “Single molecule profiling of tau gene expression in Alzheimer's disease,” Journal of Neurochemistry, vol. 103, no. 3, pp. 1228–1236, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. M. von Bergen, S. Barghorn, J. Biernat, E.-M. Mandelkow, and E. Mandelkow, “Tau aggregation is driven by a transition from random coil to beta sheet structure,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1739, no. 2, pp. 158–166, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Varani, M. G. Spillantini, M. Goedert, and G. Varani, “Structural basis for recognition of the RNA major groove in the tau exon 10 splicing regulatory element by aminoglycoside antibiotics,” Nucleic Acids Research, vol. 28, no. 3, pp. 710–719, 2000. View at Scopus
  46. E. Peacey, L. Rodriguez, Y. Liu, and M. S. Wolfe, “Targeting a pre-mRNA structure with bipartite antisense molecules modulates tau alternative splicing,” Nucleic Acids Research, vol. 40, no. 19, pp. 9836–9849, 2012. View at Publisher · View at Google Scholar
  47. E. Uhlmann, A. Peyman, G. Breipohl, and D. W. Will, “PNA: synthetic polyamide nucleic acids with unusual binding properties,” Angewandte Chemie International Edition, vol. 37, no. 20, pp. 2797–2823, 1998. View at Scopus
  48. K. Albertshofer, A. M. Siwkowski, E. V. Wancewicz et al., “Structure-activity relationship study on a simple cationic peptide motif for cellular delivery of antisense peptide nucleic acid,” Journal of Medicinal Chemistry, vol. 48, no. 21, pp. 6741–6749, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. C. F. Bennett and E. E. Swayze, “RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform,” Annual Review of Pharmacology and Toxicology, vol. 50, pp. 259–293, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. Liu, L. Rodriguez, and M. S. Wolfe, “Template-directed synthesis of a small molecule-antisense conjugate targeting an mRNA structure,” Bioorganic Chemistry, vol. 54, pp. 7–11, 2014. View at Publisher · View at Google Scholar
  51. K. R. Hande, “Clinical applications of anticancer drugs targeted to topoisomerase II,” Biochimica et Biophysica Acta, vol. 1400, no. 1–3, pp. 173–184, 1998. View at Publisher · View at Google Scholar · View at Scopus
  52. J. R. Thomas and P. J. Hergenrother, “Targeting RNA with small molecules,” Chemical Reviews, vol. 108, no. 4, pp. 1171–1224, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. A. E. Speers, G. C. Adam, and B. F. Cravatt, “Activity-based protein profiling in vivo using a copper(I)-catalyzed azide-alkyne [3 + 2] cycloaddition,” Journal of the American Chemical Society, vol. 125, no. 16, pp. 4686–4687, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. P. V. Changa, J. A. Preschera, E. M. Sletten et al., “Copper-free click chemistry in living animals,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 5, pp. 1821–1826, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. A. E. Speers and B. F. Cravatt, “Profiling enzyme activities in vivo using click chemistry methods,” Chemistry and Biology, vol. 11, no. 4, pp. 535–546, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Whiting, J. Muldoon, Y.-C. Lin et al., “Inhibitors of HIV-1 protease by using in situ click chemistry,” Angewandte Chemie International Edition, vol. 45, no. 9, pp. 1435–1439, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. W. G. Lewis, L. G. Green, F. Grynszpan et al., “Click chemistry in situ: acetylcholinesterase as a reaction vessel for the selective assembly of a femtomolar inhibitor from an array of building blocks,” Angewandte Chemie International Edition, vol. 41, no. 6, pp. 1053–1057, 2002.
  58. R. Manetsch, A. Krasiński, Z. Radić et al., “In situ click chemistry: enzyme inhibitors made to their own specifications,” Journal of the American Chemical Society, vol. 126, no. 40, pp. 12809–12818, 2004. View at Scopus
  59. V. P. Mocharla, B. Colasson, L. V. Lee et al., “In situ click chemistry: enzyme-generated inhibitors of carbonic anhydrase II,” Angewandte Chemie International Edition, vol. 44, no. 1, pp. 116–120, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. A. Krasiński, Z. Radić, R. Manetsch et al., “In situ selection of lead compounds by click chemistry: target-guided optimization of acetylcholinesterase inhibitors,” Journal of the American Chemical Society, vol. 127, no. 18, pp. 6686–6692, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. A. T. Poulin-Kerstein and P. B. Dervan, “DNA-Templated Dimerization of Hairpin Polyamides,” Journal of the American Chemical Society, vol. 125, no. 51, pp. 15811–15821, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. R. Kumar, A. El-Sagheer, J. Tumpane, P. Lincoln, L. M. Wilhelmsson, and T. Brown, “Template-directed oligonucleotide strand ligation, covalent intramolecular DNA circularization and catenation using click chemistry,” Journal of the American Chemical Society, vol. 129, no. 21, pp. 6859–6864, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. N. Kashiwagi, K. Yamashita, H. Furuta, and Y. Ikawa, “Designed RNAs with two peptide-binding units as artificial templates for native chemical ligation of RNA-binding peptides,” ChemBioChem, vol. 10, no. 17, pp. 2745–2752, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. Y. Xu, Y. Suzuki, and M. Komiyama, “Click chemistry for the identification of g-quadruplex structures: discovery of a DNA-RNA g-quadruplex,” Angewandte Chemie International Edition, vol. 48, no. 18, pp. 3281–3284, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. J. R. Dickson, C. Kruse, D. R. Montagna, B. Finsen, and M. S. Wolfe, “Alternative polyadenylation and miR-34 family members regulate tau expression,” Journal of Neurochemistry, vol. 127, no. 6, pp. 739–749, 2013. View at Publisher · View at Google Scholar
  66. L. W. Barrett, S. Fletcher, and S. D. Wilton, “Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements,” Cellular and Molecular Life Sciences, vol. 69, no. 21, pp. 3613–3634, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. J.-M. Chen, C. Férec, and D. N. Cooper, “A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes I: general principles and overview,” Human Genetics, vol. 120, no. 1, pp. 1–21, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. Y. Shi, “Alternative polyadenylation: new insights from global analyses,” RNA, vol. 18, no. 12, pp. 2105–2117, 2012. View at Publisher · View at Google Scholar
  69. P. Poorkaj, A. Kas, I. D'Souza et al., “A genomic sequence analysis of the mouse and human microtubule-associated protein tau,” Mammalian Genome, vol. 12, no. 9, pp. 700–712, 2001. View at Publisher · View at Google Scholar · View at Scopus
  70. K. R. Mowrer and M. S. Wolfe, “Promotion of BACE1 mRNA alternative splicing reduces amyloid β-peptide production,” The Journal of Biological Chemistry, vol. 283, no. 27, pp. 18694–18701, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. O. Zohar, S. Cavallaro, V. D'Agata, and D. L. Alkon, “Quantification and distribution of β-secretase alternative splice variants in the rat and human brain,” Molecular Brain Research, vol. 115, no. 1, pp. 63–68, 2003. View at Publisher · View at Google Scholar · View at Scopus
  72. L. Hong, G. Koelsch, X. Lin et al., “Structure of the protease domain of memapsin 2 (β-secretase) complexed with inhibitor,” Science, vol. 290, no. 5489, pp. 150–153, 2000. View at Publisher · View at Google Scholar · View at Scopus
  73. U. Bodendorf, F. Fischer, D. Bodian, G. Multhaup, and P. Paganetti, “A splice variant of β-secretase deficient in the amyloidogenic processing of the amyloid precursor protein,” The Journal of Biological Chemistry, vol. 276, no. 15, pp. 12019–12023, 2001. View at Publisher · View at Google Scholar · View at Scopus
  74. R. Ehehalt, B. Michel, D. de Pietri Tonelli, D. Zacchetti, K. Simons, and P. Keller, “Splice variants of the β-site APP-cleaving enzyme BACE1 in human brain and pancreas,” Biochemical and Biophysical Research Communications, vol. 293, no. 1, pp. 30–37, 2002. View at Publisher · View at Google Scholar · View at Scopus
  75. H. Tanahashi and T. Tabira, “Three novel alternatively spliced isoforms of the human beta-site amyloid precursor protein cleaving enzyme (BACE) and their effect on amyloid beta-peptide production,” Neuroscience Letters, vol. 307, no. 1, pp. 9–12, 2001. View at Publisher · View at Google Scholar · View at Scopus
  76. J.-F. Fisette, D. R. Montagna, M.-R. Mihailescu, and M. S. Wolfe, “A G-Rich element forms a G-quadruplex and regulates BACE1 mRNA alternative splicing,” Journal of Neurochemistry, vol. 121, no. 5, pp. 763–773, 2012. View at Publisher · View at Google Scholar · View at Scopus
  77. S. Balasubramanian and S. Neidle, “G-quadruplex nucleic acids as therapeutic targets,” Current Opinion in Chemical Biology, vol. 13, no. 3, pp. 345–353, 2009. View at Publisher · View at Google Scholar · View at Scopus